Barclays Cuts Clorox (NYSE:CLX) Price Target to $134.00

Clorox (NYSE:CLX) had its target price decreased by analysts at Barclays from $139.00 to $134.00 in a report released on Friday,Benzinga reports. The brokerage currently has an “underweight” rating on the stock. Barclays‘s price target points to a potential downside of 5.20% from the stock’s previous close.

CLX has been the subject of a number of other reports. JPMorgan Chase & Co. cut their price target on shares of Clorox from $173.00 to $151.00 and set a “neutral” rating for the company in a report on Friday. Evercore ISI boosted their target price on shares of Clorox from $145.00 to $155.00 in a report on Tuesday, February 4th. DA Davidson reduced their target price on shares of Clorox from $171.00 to $169.00 and set a “neutral” rating for the company in a report on Wednesday, February 5th. StockNews.com lowered shares of Clorox from a “buy” rating to a “hold” rating in a research report on Sunday, January 5th. Finally, Wells Fargo & Company cut their price objective on Clorox from $161.00 to $155.00 and set an “equal weight” rating for the company in a research report on Wednesday, April 2nd. Three equities research analysts have rated the stock with a sell rating, ten have given a hold rating and one has issued a buy rating to the company’s stock. According to data from MarketBeat, the stock presently has an average rating of “Hold” and a consensus price target of $156.75.

Clorox Price Performance

Shares of NYSE:CLX traded up $0.45 during trading on Friday, reaching $141.35. The company had a trading volume of 1,238,514 shares, compared to its average volume of 1,473,174. The firm’s fifty day moving average is $147.53 and its 200 day moving average is $157.39. The company has a debt-to-equity ratio of 20.52, a quick ratio of 0.60 and a current ratio of 0.94. The firm has a market capitalization of $17.41 billion, a PE ratio of 38.62, a price-to-earnings-growth ratio of 2.62 and a beta of 0.61. Clorox has a twelve month low of $127.60 and a twelve month high of $171.37.

Clorox (NYSE:CLX) last released its earnings results on Monday, February 3rd. The company reported $1.55 earnings per share for the quarter, topping analysts’ consensus estimates of $1.39 by $0.16. Clorox had a return on equity of 316.87% and a net margin of 6.38%. During the same period in the prior year, the business earned $2.16 earnings per share. On average, equities analysts forecast that Clorox will post 7.15 EPS for the current year.

Institutional Inflows and Outflows

Several hedge funds have recently bought and sold shares of the company. MML Investors Services LLC lifted its stake in Clorox by 9.7% in the third quarter. MML Investors Services LLC now owns 8,959 shares of the company’s stock valued at $1,460,000 after acquiring an additional 792 shares during the last quarter. Continuum Advisory LLC boosted its holdings in Clorox by 300.0% in the third quarter. Continuum Advisory LLC now owns 184 shares of the company’s stock worth $30,000 after purchasing an additional 138 shares in the last quarter. M&T Bank Corp increased its position in Clorox by 0.9% during the third quarter. M&T Bank Corp now owns 30,858 shares of the company’s stock worth $5,027,000 after buying an additional 287 shares during the last quarter. Geode Capital Management LLC raised its holdings in Clorox by 1.1% during the third quarter. Geode Capital Management LLC now owns 3,028,333 shares of the company’s stock valued at $491,713,000 after buying an additional 33,970 shares in the last quarter. Finally, Coldstream Capital Management Inc. lifted its position in shares of Clorox by 128.5% in the third quarter. Coldstream Capital Management Inc. now owns 3,626 shares of the company’s stock worth $595,000 after buying an additional 2,039 shares during the last quarter. 78.53% of the stock is owned by institutional investors and hedge funds.

About Clorox

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.